AMP Annual Meeting & Expo (Association for Molecular Pathology)
Join us at the AMP Annual Meeting & Expo 2024!
November 19 - 23, 2024
Vancouver, British Columbia (Canada)
Booth #1225
Corporate workshop
Wednesday, November 20th
10:00 AM – 10:50 AM
Vancouver Convention Center, Level 2, Room 208 & 209
Title: The value of internalizing FDA- authorized tumor genomic profiling solutions for tissue and liquid biopsy
Description: Clinical NGS has advanced precision oncology, enabling physicians to identify actionable biomarkers in patients to aid in therapy selection. This workshop highlights the value of internalizing FDA-cleared tissue and an FDA authorized targeted liquid biopsy tumor profiling kitted solutions with best-in-class bioinformatics to help provide greater access to cancer patients worldwide. This workshop will also showcase our new FDA de novo authorized liquid biopsy kitted solution and examine the validation data included in the FDA submission. Lastly, there will be a panel discussion of active users who will discuss their point of view on the value of internalizing these solutions.
Innovation Spotlight Stage
Thursday, November 21st
12:40 PM – 1:10 PM
Innovation Spotlight Stage #2
Title: Enabling access to genomic profiling through the FDA- authorized decentralized liquid biopsy solution, PGDx elio™ plasma focus Dx
Description: Liquid biopsy next-generation sequencing assays help guide treatment selection in cancer patients, particularly when tumor tissue is unavailable. Analytical validation an FDA authorized targeted 33-gene kitted assay, PGDx elio™ plasma focus Dx, has shown that detection of cancer-associated variants in ctDNA is highly specific, sensitive, reproducible and accurate.